10
Aug
Aug
Canada — August 2026 — LifeVac Canada is pleased to announce a major milestone for LifeVac following authorization by the U.S. Food and Drug Administration. On March 4, 2026, the FDA granted LifeVac De Novo authorization, establishing a new device classification for a “suction anti-choking device as a second-line treatment” intended for use when standard [...]